Galenica Sante Ag Stock Current Valuation
| GALE Stock | CHF 70.55 0.55 0.79% |
Valuation analysis of Galenica Sante AG helps investors to measure Galenica Sante's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Galenica Sante's price fluctuation is very steady at this time. Calculation of the real value of Galenica Sante AG is based on 3 months time horizon. Increasing Galenica Sante's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Galenica Sante AG is useful when determining the fair value of the Galenica stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Galenica Sante. Since Galenica Sante is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Galenica Stock. However, Galenica Sante's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 70.55 | Real 71.84 | Hype 70.55 |
The real value of Galenica Stock, also known as its intrinsic value, is the underlying worth of Galenica Sante AG Company, which is reflected in its stock price. It is based on Galenica Sante's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Galenica Sante's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Galenica Sante's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Galenica Sante AG helps investors to forecast how Galenica stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Galenica Sante more accurately as focusing exclusively on Galenica Sante's fundamentals will not take into account other important factors: Galenica Sante AG Company Current Valuation Analysis
Galenica Sante's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Galenica Sante Current Valuation | 4.26 B |
Most of Galenica Sante's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galenica Sante AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Galenica Sante AG has a Current Valuation of 4.26 B. This is 70.37% lower than that of the Healthcare sector and 8.39% lower than that of the Biotechnology industry. The current valuation for all Switzerland stocks is 74.4% higher than that of the company.
Galenica Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galenica Sante's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galenica Sante could also be used in its relative valuation, which is a method of valuing Galenica Sante by comparing valuation metrics of similar companies.Galenica Sante is currently under evaluation in current valuation category among related companies.
Galenica Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0492 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.26 B | |||
| Shares Outstanding | 49.64 M | |||
| Shares Owned By Insiders | 0.17 % | |||
| Shares Owned By Institutions | 49.77 % | |||
| Price To Earning | 16.37 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 3.83 B | |||
| Gross Profit | 427.92 M | |||
| EBITDA | 305.98 M | |||
| Net Income | 167.68 M | |||
| Cash And Equivalents | 164.98 M | |||
| Cash Per Share | 2.13 X | |||
| Total Debt | 579.88 M | |||
| Debt To Equity | 43.80 % | |||
| Current Ratio | 1.77 X | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | 333.1 M | |||
| Earnings Per Share | 3.45 X | |||
| Target Price | 70.0 | |||
| Number Of Employees | 5.52 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 3.74 B | |||
| Total Asset | 2.57 B | |||
| Z Score | 4.6 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 2.57 B | |||
| Last Dividend Paid | 2.1 |
About Galenica Sante Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galenica Sante AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galenica Sante using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galenica Sante AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galenica Sante AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Galenica Stock analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |